New York, NY, United States of America

Radha Moorthy

This inventor holds 1 USPTO granted patent. Top assignee: Diakron Pharmaceuticals, Inc.. Active years: 2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Radha Moorthy. Retrieved from https://idiyas.com/inventor/radha-moorthy

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Radha Moorthy: Innovator in Anti-Diabetic and Cholesterol Lowering Preparations

Introduction

Radha Moorthy is a notable inventor based in New York, NY (US). He has made significant contributions to the field of health and nutrition through his innovative research and development.

Latest Patents

Radha Moorthy holds a patent for an "Anti-diabetic and cholesterol lowering preparation from fenugreek seeds." This invention relates to a composition that exhibits blood glucose-lowering and cholesterol-lowering activity, derived from seeds of the Papilinaceae Leguminosae family, specifically fenugreek seeds. The patent details methods for obtaining the composition from the seeds and their parts, as well as therapeutic methods for treating diabetes and hypercholesterolemia.

Career Highlights

Radha Moorthy is currently associated with Diakron Pharmaceuticals, Inc., where he continues to work on innovative solutions in the pharmaceutical industry. His dedication to research and development has positioned him as a key player in the field.

Collaborations

Radha has collaborated with notable coworkers, including Pothapragada Suryanarayana Murthy and K M Prabhu, who contribute to the innovative environment at Diakron Pharmaceuticals, Inc.

Conclusion

Radha Moorthy's work in developing anti-diabetic and cholesterol-lowering preparations showcases his commitment to improving health outcomes through innovation. His contributions are significant in the ongoing battle against diabetes and high cholesterol levels.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…